These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11675827)

  • 1. [Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].
    Iacoviello L; Donati MB; de Gaetano G
    Ital Heart J Suppl; 2001 Sep; 2(9):1031-3. PubMed ID: 11675827
    [No Abstract]   [Full Text] [Related]  

  • 2. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
    Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
    Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
    Ridker PM; Stampfer MJ; Rifai N
    JAMA; 2001 May; 285(19):2481-5. PubMed ID: 11368701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel risk factors for heart disease. An interview with Gerald Gau, M.D.
    Gau G
    Mayo Clin Womens Healthsource; 2005 Jun; 9(6):S1-2. PubMed ID: 15888993
    [No Abstract]   [Full Text] [Related]  

  • 5. [Homocysteine--CRP--lipoprotein (a). When do you evaluate the "new" risk factors].
    Parhofer KG
    MMW Fortschr Med; 2001 Jan; 143(4):22-4. PubMed ID: 11219276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Less common risk factors for atherogenesis--homocysteine, lipoprotein (a) and C-reactive protein].
    Racek J; Racková M
    Cas Lek Cesk; 2002 Sep; 141(19):605-9. PubMed ID: 12501503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel risk factors for atherosclerosis.
    Kullo IJ; Gau GT; Tajik AJ
    Mayo Clin Proc; 2000 Apr; 75(4):369-80. PubMed ID: 10761492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein: a predictor of peripheral artery disease.
    Harv Heart Lett; 1998 Jul; 8(11):6-7. PubMed ID: 9666755
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel risk factors and markers for coronary disease.
    Ridker PM
    Adv Intern Med; 2000; 45():391-418. PubMed ID: 10635056
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for progression of peripheral arterial disease in large and small vessels.
    Aboyans V; Criqui MH; Denenberg JO; Knoke JD; Ridker PM; Fronek A
    Circulation; 2006 Jun; 113(22):2623-9. PubMed ID: 16735675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerotic renal artery stenosis: association with emerging vascular risk factors.
    Paraskevas KI; Hamilton G; Cross JM; Mikhailidis DP
    Nephron Clin Pract; 2008; 108(1):c56-66. PubMed ID: 18097149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microalbuminuria and atherosclerosis risk factors in potentially healthy men--preliminary data].
    Kade G; Wierzbicki P; Prokopiuk-Wierzbicka M; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):114-8. PubMed ID: 15603318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic status as an independent predictor of physiological biomarkers of cardiovascular disease: evidence from NHANES.
    Muennig P; Sohler N; Mahato B
    Prev Med; 2007 Jul; 45(1):35-40. PubMed ID: 17521717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study.
    McDermott MM; Guralnik JM; Corsi A; Albay M; Macchi C; Bandinelli S; Ferrucci L
    Am Heart J; 2005 Aug; 150(2):276-81. PubMed ID: 16086930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cardiac markers.
    Alder R
    Adv Nurse Pract; 2009 Jun; 17(6):24-7; quiz 28. PubMed ID: 20000180
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
    Sarafidis PA; Lasaridis AN; Nilsson PM; Mouslech TF; Hitoglou-Makedou AD; Stafylas PC; Kazakos KA; Yovos JG; Tourkantonis AA
    Metabolism; 2005 Sep; 54(9):1236-42. PubMed ID: 16125536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the risk factors for atherosclerosis on levels of soluble adhesion molecules and endothelial markers in peripheral vascular disease.
    Blann AD; Lip GY; McCollum CN
    Thromb Haemost; 2002 Aug; 88(2):366-7. PubMed ID: 12195717
    [No Abstract]   [Full Text] [Related]  

  • 18. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
    Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT
    Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Emerging risk factors for cardiovascular disease].
    Demant T
    Dtsch Med Wochenschr; 2004 Jan; 129(5):204-9. PubMed ID: 14735418
    [No Abstract]   [Full Text] [Related]  

  • 20. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
    Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.